On the inefficiency of the adaptive design for monitoring clinical trials
From MaRDI portal
Publication:4455417
DOI10.1093/BIOMET/90.2.367zbMATH Open1034.62069OpenAlexW2048014796MaRDI QIDQ4455417FDOQ4455417
Authors: Anastasios A. Tsiatis, Cyrus R. Mehta 
Publication date: 16 March 2004
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://semanticscholar.org/paper/b872af483adb03dfa91262ca4f20af3751dc63ea
Recommendations
- scientific article; zbMATH DE number 1361706
- Some recent developments in the design of adaptive clinical trials
- Adaptive design methods in clinical trials
- Adaptive designs for noninferiority trials
- Some optimal adaptive designs in clinical trials
- On the efficiency of adaptive designs for flexible interim decisions in clinical trials
- An adaptive design for multi-arm clinical trials
- Optimal adaptive randomized designs for clinical trials
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)
Cited In (20)
- Internal pilots for observational studies
- Are Flexible Designs Sound?
- Adaptive and nonadaptive group sequential tests
- Flexible Designs for Genomewide Association Studies
- Adaptive randomized trial designs that cannot be dominated by any standard design at the same total sample size
- Bandit Theory: Applications to Learning Healthcare Systems and Clinical Trials
- Sample size adaptation designs and efficiency comparison with group sequential designs
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
- On the efficiency of adaptive sample size design
- Optimal planning of adaptive two-stage designs
- Optimal adaptive promising zone designs
- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials
- Statistical Inference for Self‐Designing Clinical Trials with a One‐Sided Hypothesis
- On the efficiency of adaptive designs for flexible interim decisions in clinical trials
- Designing a longitudinal clinical trial based on a composite endpoint: sample size, monitoring, and adaptation
- Benefit–Risk Evaluation of Multi-Stage Adaptive Designs
- α-Investing: a Procedure for Sequential Control of Expected False Discoveries
- Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes
- Monitoring Accumulating Data in a Clinical Trial
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
This page was built for publication: On the inefficiency of the adaptive design for monitoring clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4455417)
